Biopharma Target Price 10 Times Current
Source: Dr. Elemer Piros  (10/6/22)
Read to learn why ROTH Capital Partners gave Atai Life Sciences NV a Buy rating and a target price 10 times its current. More >

Biotech Co.'s Drug Showing 'Early Signs of Benefit'
Source: Dr. Elemer Piros  (10/6/22)
With this upcoming analysis, the board will determine whether the Phase 2b/3 trial may continue to completion, noted a ROTH Capital Partners report. More >

Trial Results of New Drug for An Eye Disease 'Encouraging'
Source: Dr. Yale Jen  (10/6/22)
The data suggest this treatment could be safer and more effective in treating proliferative vitreoretinopathy than compounded methotrexate, noted a Laidlaw & Co. report. More >

Resource Could Reach 42.5 Mt, Analyst Says
Source: Adam Schatzker  (10/5/22)
Deposit upside at this polymetallic project in Spain is indicated by the historical mineral resource and past and current drill results, noted a Research Capital Corp. report. More >

Gold Junior Looks To Expand Resources at Nevada Project
Source: Streetwise Reports  (10/4/22)
Drilling is underway at this company’s project in northern Nevada, where it hopes to expand its resources with help from a major. More >

B.C. Mine on Verge of Producing Gold
Source: Bill Newman  (10/4/22)
Placer gold recovery at this project is expected to start in the coming months after mine stabilization is completed, noted a Research Capital Corp. report. More >

Expert Says, 'Watch US 10-Year Treasury Yield as Your Night Sextant'
Source: Michael Ballanger  (10/4/22)
Expert Michael Ballanger takes a moment to review current updates in the stock market, including the position of gold, the current Fed mandate, the outlook of Getchell Gold Corp., and the Nord Stream Gas Pipelines. More >

COMSAT Co. Sells TDL Business for $1.96B
Source: Streetwise Reports  (10/4/22)
Shares of Viasat Inc. traded 27% higher yesterday after the global communications firm reported it has agreed to sell its Link 16 Tactical Data Links Business to L3Harris Technologies for US$1.96 billion. More >

Green Tech Co. Gets Environmental Impact Approval in Ecuador
Source: Streetwise Reports  (10/4/22)
Now BacTech Environmental Corp. must pursue the community consultation phase before receiving final environmental permit for its Tenguel bioleaching plant. More >

Charts for Lithium Co. Show It's 'Heading Higher'
Source: Clive Maund  (10/4/22)
In light of yesterday's lithium results from Argentina Lithium & Energy Corp., expert Clive Maund takes a look at the 10-year, 15-month, and 6-month charts for the natural resource company to tell you his outlook. More >

Magnetite Points Copper Junior in Right Direction for Drilling
Source: Streetwise Reports  (10/3/22)
Infinitum Copper Corp. continues to get impressive results from its drilling campaign at its flagship project in Mexico, but another discovery is helping to point the way to future exploration. More >

Junior Explorer Doubles Its Copper Play With Co. Purchase
Source: Streetwise Reports  (10/3/22)
Junior explorer Alpha Copper Corp. is trying to get ahead of the crush for more copper for the green revolution by doubling the number of its projects with a new purchase. More >

Co. Uses RNA Editing as Treatment for Rare Disease
Source: Andrew Fein  (10/3/22)
The firm plans to advance its alpha-1 antitrypsin deficiency program into the clinic next year, noted an H.C. Wainwright & Co. report. More >

Drilling Underway To Find Lode Gold Source at B.C. Project
Source: Bill Newman  (10/3/22)
Results of this program, expected to be done in November, could cause the company's stock to react upward, noted a Research Capital Corp. report. More >

Mining Co. Makes an Unexpected but Attractive Acquisition
Source: Adrian Day  (10/3/22)
Today, expert Adrian Day reviews the latest acquisition by Agnico Eagle Mines Ltd. and shares his thoughts on some of the resource companies on his list. More >

Pure Play Copper Mining Co. at Good Entry Point for Investors
Source: Taylor Combaluzier  (10/1/22)
This company with early-stage exploration projects with blue sky potential just garnered analyst coverage by Red Cloud Securities, a firm report noted. More >

Interim Results From Phase 2b Trial Are 'Encouraging'
Source: Dr. Elemer Piros  (9/30/22)
Data show the biotech's compound had a positive effect on several noninvasive measures, noted a ROTH Capital Partners report. More >

Miner Finds Vast Nickel System in Brazil
Source: Streetwise Reports  (9/30/22)
Ero Copper Corp. shares traded more than 7% higher on a down market yesterday after the company reported it discovered a new nickel sulfide system within Brazil's Curaçá Valley. In an area historically known for rich copper deposits, the firm reported that drill results from the system's VB zone returned 16.5m of 1.22% nickel which included 3.8m of 3.60% nickel. More >

Clean Tech Co. Might Be 'Intrinsically Strong'
Source: Clive Maund  (9/30/22)
Expert Clive Maund reviews Ecolomondo Corp.'s 6-month and 2-year charts to show you why he believes this stock may be strong no matter the market. More >

Biopharma Co. Awarded FDA Clearance for Advanced Solid Tumors Trial
Source: Streetwise Reports  (9/30/22)
Shares of oncology-focused biopharmaceutical company Immuneering Corp. traded 9% higher after the firm reported it received U.S. FDA clearance for its IND Application for a Phase 1/2a clinical trial of IMM-1-104 for use in treatment of advanced solid tumors with RAS mutations. The company expects to enroll the first patient in the study in Q4/22. More >

Pharma Co. Meets Primary Endpoint in Phase 3 Alzheimer's Trial
Source: Streetwise Reports  (9/29/22)
Shares of Eisai Co. Ltd. traded 58% higher yesterday after the company reported topline data from its global Phase 3 clinical study demonstrating that its lecanemab significantly met the primary and key secondary endpoints in reducing mild cognitive impairment due to Alzheimer's disease. More >

Silver Explorer 'Could Be Sitting on Three-Four Million Ounces'
Source: Chris Temple  (9/29/22)
After speaking with the president and CEO of Arizona Silver Exploration Inc., editor and publisher of The National Investor, Chris Temple, shares why he believes its Philadelphia Project is compelling. More >

Expert Says Lithium Co. 'An Immediate Speculative Buy'
Source: Clive Maund  (9/29/22)
Expert Clive Maund takes a look at the 6-month and 2-year charts for Spey Resources Corp., following the completion of a large base pattern, to tell you whether he believes it is a Buy. More >

Biopharma Asks for Emergent Use in US of New COVID Drug
Source: Edward White  (9/29/22)
The requested approval is specifically for critically ill patients, a population for which the U.S. Food and Drug Administration granted the therapeutic fast track status, noted an H.C. Wainwright & Co. report. More >

Co. Builds Copper Gold Resource at Asset Near Large Miner
Source: Siddharth Rajeev  (9/28/22)
This mining firm with a robust project portfolio is exploring its newly acquired asset in Chile's Atacama region, from which results are expected soon, noted a Fundamental Research Corp. report. More >